Document is current
Any future updates will be listed below
-
Authors
Virshup, Isaac https://orcid.org/0000-0002-1710-8945
Bredikhin, Danila https://orcid.org/0000-0001-8089-6983
Heumos, Lukas
Palla, Giovanni https://orcid.org/0000-0002-8004-4462
Sturm, Gregor https://orcid.org/0000-0001-9584-7842
Gayoso, Adam https://orcid.org/0000-0001-9537-0845
Kats, Ilia https://orcid.org/0000-0001-5220-5671
Koutrouli, Mikaela https://orcid.org/0000-0002-8953-3561
,
Angerer, Philipp
Bergen, Volker
Boyeau, Pierre
Büttner, Maren
Eraslan, Gokcen
Fischer, David https://orcid.org/0000-0002-1293-7656
Frank, Max
Hong, Justin https://orcid.org/0000-0003-2115-9101
Klein, Michal
Lange, Marius https://orcid.org/0000-0002-4846-1266
Lopez, Romain https://orcid.org/0000-0003-0495-738X
Lotfollahi, Mohammad https://orcid.org/0000-0001-6858-7985
Luecken, Malte D.
Ramirez, Fidel
Regier, Jeffrey https://orcid.org/0000-0002-1472-5235
Rybakov, Sergei
Schaar, Anna C.
Valiollah Pour Amiri, Valeh https://orcid.org/0000-0002-2008-5297
Weiler, Philipp https://orcid.org/0000-0002-0992-7043
Xing, Galen
Berger, Bonnie
Pe’er, Dana https://orcid.org/0000-0002-9259-8817
Regev, Aviv https://orcid.org/0000-0003-3293-3158
Teichmann, Sarah A. https://orcid.org/0000-0002-6294-6366
Finotello, Francesca https://orcid.org/0000-0003-0712-4658
Wolf, F. Alexander https://orcid.org/0000-0002-8760-7838
Yosef, Nir https://orcid.org/0000-0001-9004-1225
Stegle, Oliver
Theis, Fabian J. https://orcid.org/0000-0002-2419-1943
- License Information
-
More Information
Article History
First Online: 10 April 2023
Competing interests
: F.J.T. consults for Immunai Inc., Singularity Bio B.V., CytoReason Ltd and Omniscope Ltd, and has ownership interest in Dermagnostix GmbH and Cellarity. A.R. is a co-founder of and equity holder in Celsius Therapeutics, an equity holder in Immunitas, and until 31 July 2020 was a scientific advisory board member of Thermo Fisher Scientific, Syros Pharmaceuticals, Neogene Therapeutics and Asimov. From 1 August 2020, A.R. has been an employee of Genentech and a member of the Roche Group, and has equity in Roche. M.D.L is a part-time contractor for the Chan Zuckerberg Initiative. V.B. reports being employed by and having ownership interest in Cellarity. G.E. has been an employee of Genentech since 4 April 2022. R.L. has been an employee of Genentech since 31 August 2021. F.A.W. holds equity in Lamin Labs, Cellarity, Retro Biosciences and Doloromics. N.Y. is an advisor to and/or has equity in Cellarity, Celsius Therapeutics and Rheos Medicines. The remaining authors declare no competing interests.
